Medasense

1 known investors

Medasense develops AI-powered pain monitoring technology for critical care settings, using its NOL sensor platform and algorithms to quantify pain response and personalize anesthetic treatment. The company's PMD-200 device helps hospitals reduce postoperative pain and avoid medication overuse.